REFERENCES
- Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9:16–23.
- Bush A. The lungs in uremia. Semin Respir Med. 1988;9:273–282.
- Iseki K, Fuliyama K. Long-term prognosis and incidence of acute myocardial infarction in patients on chronic hemodialysis. The Okinawa Dialysis Study Group. Am J Kidney Dis. 2000;36:820–825.
- Bellinghieri G, Santoro D, Calvani M, Carnitine and hemodialysis. Am J Kidney Dis. 2003;41:116–122.
- Dawson B, Trapp RG. Basic and clinical biostatistics. New York: McGraw-Hill Companies; 2004:69–70.
- American Thoracic Society. Standardization of spirometry, 1997 update. Am Rev Respir Dis. 1997;136:1285–1298.
- Wan L, Hubbard RW. Determination of free and total carnitine with a random-access chemistry analyzer. Clin Chem. 1998;44:810–816.
- Ahmad S, Robertson HT, Golper TA, Multicenter trial of L-carnitine in maintenance. II. Clinical and biochemical effects. Kidney Int. 1990;38:912–918.
- RogersonM E, Rylance PB, Wilson R, Carnitine and weakness in hemodialysis patients. Nephrol Dial Transplant. 1989;4:366–371.
- Feinfeld DA, Kurian P, Cheng JT, Effect of oral L-carnitine on serum myoglobin in hemodialysis paitents. Ren Fail. 1996; 18:91–96.
- Calvani M, Benatti P, Mancinelli A, Carnitine replacement in end-stage renal disease and hemodialysis. Ann NY Acad Sci. 2004;1033:52–66.
- Duranay M, Akay H, Yılmaz FM, Effects of L-carnitine infusions on inflammatory and nutritional markers in hemodialysis patients. Nephrol Dial Transplant. 2006;22: 1–4.
- Savica V, Santoro D, Mazzaglia G, L-carnitine infusions may supress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients. J Ren Nutr. 2005; 15:225–230.
- Backer WA, Linz RR, Broe M. Pulmonary aspects of dialysis patients. In Moher JF ( ed.). Replacement of renal function by dialysis. 3rd ed. Lanchester: Kluwer Academic Publishers; 1988:827–839.
- Bonnefont-Rousselot D, Lehmann E, Jaudon MC, Blood oxidative stress and lipoprotein oxidizability in hemodialysis patients: Effect of the use of a vitamin E-coated dialysis membrane. Nephrol Dial Transplant. 2000; 15:2020–2028.
- Izgut-Uysal VN, Agac A, Derin N. Effect of carnitine on stress-induced lipid peroxidation in rat gastric mucosa. Gastroenterology. 2001;36:231–236.
- Ahmad S, Dasgupta A, Kenny MA. Fatty acid abnormalities in hemodialysis patients: Effect of L-carnitine administration. Kidney Int. 1989;36:243–246.
- Uzuner N, Kavukçu S, Yilmaz O, The role of L-carnitine in treatment of a murine model of asthma. Acta Med Okayama. 2002;56:295–301.
- Kavukcu S, Turkmen M, Salman S, The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis. Turk J Pediatr. 1998; 40:79–84.
- Uzuner N, Kavukçu S, Karaman O. L-carnitine does not exert any in vitro relaxant effect in guinea pig trachea, lung parenchyma and human bronchial tissue. Experimental Lung Research. 2002;28:485–492.